Treatment of choice in 11 years old children with hepatitic C infections
## **Core Concept**
The treatment of hepatitis C infection has evolved over the years, especially in pediatric patients. The goal is to achieve sustained virological response (SVR), which indicates a cure. In children, the treatment choice depends on the genotype of the virus, the presence of liver damage, and the patient's age.
## **Why the Correct Answer is Right**
The correct answer, **Sofosbuvir and Ledipasvir**, is a combination of direct-acting antivirals (DAAs) that has been shown to be highly effective in treating hepatitis C virus (HCV) infection in both adults and children. Sofosbuvir is a nucleotide NS5B polymerase inhibitor, and Ledipasvir is an NS5A inhibitor. This combination has a high barrier to resistance and is well-tolerated, making it suitable for pediatric patients. The use of DAAs has revolutionized HCV treatment, offering a shorter duration of therapy (usually 12 weeks) and a higher cure rate compared to traditional interferon-based therapies.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although Ribavirin is sometimes used in combination with other medications for treating HCV, it is not typically used alone or as a first-line treatment in children due to its side effect profile and the availability of more effective treatments.
- **Option B:** This option is incorrect as it does not provide a specific treatment regimen. Without details on the medication, it's impossible to assess its relevance.
- **Option D:** This option is incorrect because Interferon-based therapies are less commonly used nowadays due to their lower efficacy, longer treatment duration, and significant side effects compared to DAAs like Sofosbuvir and Ledipasvir.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the treatment of HCV in pediatric patients is genotype-dependent and that Sofosbuvir and Ledipasvir combination is approved for children as young as 3 years old, offering a highly effective and well-tolerated treatment option. Always consider the viral genotype and the potential for drug interactions when selecting a treatment regimen.
## **Correct Answer:** D. Sofosbuvir and Ledipasvir